Real-world effectiveness of influenza vaccine against medical-attended influenza infection during 2023/24 season in Ili Kazakh Autonomous Prefecture, China: A test-negative, case-control study
In the post-COVID-19 pandemic era, influenza virus infections continuously lead to a global disease burden. Evaluating vaccine effectiveness against influenza infection is crucial to inform vaccine design and vaccination strategy. In this study, we recruited 1120 patients with influenza-like illness...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Book |
| Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_56c822b6536b4c38b77d4de676554f0f | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Jia Mi |e author |
| 700 | 1 | 0 | |a Juping Wang |e author |
| 700 | 1 | 0 | |a Luping Chen |e author |
| 700 | 1 | 0 | |a Zihao Guo |e author |
| 700 | 1 | 0 | |a Hao Lei |e author |
| 700 | 1 | 0 | |a Marc KC Chong |e author |
| 700 | 1 | 0 | |a Jiangatai Talifu |e author |
| 700 | 1 | 0 | |a Shengmei Yang |e author |
| 700 | 1 | 0 | |a Kamuranni Luotebula |e author |
| 700 | 1 | 0 | |a Maierhaba Ablikemu |e author |
| 700 | 1 | 0 | |a Chunyu Ma |e author |
| 700 | 1 | 0 | |a Wenli Lu |e author |
| 700 | 1 | 0 | |a Zhaohui Luo |e author |
| 700 | 1 | 0 | |a Chuanfa Liu |e author |
| 700 | 1 | 0 | |a Shengzhi Sun |e author |
| 700 | 1 | 0 | |a Jianghong Dai |e author |
| 700 | 1 | 0 | |a Kai Wang |e author |
| 700 | 1 | 0 | |a Kailu Wang |e author |
| 700 | 1 | 0 | |a Shi Zhao |e author |
| 245 | 0 | 0 | |a Real-world effectiveness of influenza vaccine against medical-attended influenza infection during 2023/24 season in Ili Kazakh Autonomous Prefecture, China: A test-negative, case-control study |
| 260 | |b Taylor & Francis Group, |c 2024-12-01T00:00:00Z. | ||
| 500 | |a 10.1080/21645515.2024.2394255 | ||
| 500 | |a 2164-554X | ||
| 500 | |a 2164-5515 | ||
| 520 | |a In the post-COVID-19 pandemic era, influenza virus infections continuously lead to a global disease burden. Evaluating vaccine effectiveness against influenza infection is crucial to inform vaccine design and vaccination strategy. In this study, we recruited 1120 patients with influenza-like illness (ILI) who attended fever clinics of 4 sentinel hospitals in the Ili Kazakh Autonomous Prefecture, Xinjiang Uygur Autonomous Region, China, from January 1 to April 7, 2024. Using a test-negative design, we estimated influenza vaccine effectiveness (VE) of 54.7% (95% CrI: 23.7, 73.1) against medical-attended influenza infection, with 62.3% (95% CrI: 29.3, 79.8) against influenza A, and 51.2% (95% CrI: 28.7, 83.0) against influenza B. Despite the moderate VE estimated in this study, influenza vaccination remains the most important approach to prevent influenza at the community level. | ||
| 546 | |a EN | ||
| 690 | |a Influenza virus | ||
| 690 | |a vaccine effectiveness | ||
| 690 | |a test-negative study | ||
| 690 | |a influenza-like illness | ||
| 690 | |a Immunologic diseases. Allergy | ||
| 690 | |a RC581-607 | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024) | |
| 787 | 0 | |n https://www.tandfonline.com/doi/10.1080/21645515.2024.2394255 | |
| 787 | 0 | |n https://doaj.org/toc/2164-5515 | |
| 787 | 0 | |n https://doaj.org/toc/2164-554X | |
| 856 | 4 | 1 | |u https://doaj.org/article/56c822b6536b4c38b77d4de676554f0f |z Connect to this object online. |